"Mr. Liu, hello, I'm Aemond from Pfizer. Pete, Mr. Liu, you can call me Aemond. ”

As the deputy director of Pfizer, Aemond thinks he has seen many opponents, and after so many years of crawling around in the mall, he has never had an absolute opponent that makes him feel unpredictable. Pfizer, as the world's largest pharmaceutical company, is definitely the same as the US imperialist in the pharmaceutical industry. The change in this situation has changed because of the appearance of one person, and that is the young man in front of him.

Edmond despised Huaguo's scientific research and technology in his heart, and Huaguo's statins have always followed the path of imitation, and there is not even a little innovation. Especially after the expiration of atorvastatin's patent, imitations emerged in the entire Chinese market, which did not make Pfizer take it to heart at all, until it was rumored that Huaguo's latest statin drugs had incomparable advantages over atorvastatin in terms of effect and price. Although Lipitor is no longer their main product, no one wants to give up the huge benefits of it.

The launch of the new drug has directly impacted all statin drugs in the Chinese market, especially the two statins imported from abroad, Lipitor and Codine. Although the manufacturer of the drug has nothing to do with Boyuan, everyone in this industry knows how much they paid to Boyuan to produce this drug. This time, Aemond personally came to cook and learned that Boyuan Pharmaceutical Group and Longhai Pharmaceutical Co., Ltd., which are subordinate to Boboyuan Group, have begun to develop two new drugs. One is to lower blood pressure, and the other new drug has not yet been released, but Emond believes that as long as these two drugs are on the market, it will definitely bring a new round of impact to the drug market.

"Mr. Emond, speaking of which, I still have a little bit of a relationship with Pfizer." Liu Tao looked at Aemond with a smile and motioned for the other party to continue.

"If Mr. Liu had stayed in our company, maybe he wouldn't have had his current achievements." Aemond speaks Chinese, and although he despises the scientific research and technology of China, he must admit that the culture and language of China are truly wonderful and fascinating.

"Who knows if there is such an achievement, but it is certain that I will not have the current achievement." Liu Tao also made a small joke with Aemond. Everybody is smart. Both of them smiled knowingly.

Liu Tao has said on countless occasions that if you want to do it, you must be the best, and the current leader in the pharmaceutical industry is himself, and he has said it more than once. Knock them out with medicine. Originally, it was not a big man like him who came to seek cooperation this time. But for the sake of caution. At the same time, in order to find out the hole cards of Boyuan Group, he finally chose to come to Huaguo to negotiate with Boyuan Group in person.

"Mr. Emond, the first thing I want to make clear is that I have no ill will towards Pfizer. Pfizer has expanded rapidly over the years and has always been the leader in our pharmaceutical industry. Liu Tao saw that Aemond was not good, and he also had no patience to continue to think of a snake with him: "As long as the people who cooperate with me are very clear, my business will either not do it, but do the best, so what company is in the way, I think you and I know very well in my heart." ”

"This is natural, we at Pfizer have never been challenged, but Mr. Liu, you know that the research and development of a drug is not a matter of one or two years, and the investment in drug research and development alone is definitely not a small amount." Aemond made a move that you understand: "Mr. Liu, from the beginning of the development of a drug to the final market, it may take between one billion and two billion US dollars, of course, we are talking about drugs that absolutely improve symptoms, and we don't count ordinary drugs." ”

"Mr. Liu, you know that our company invests a lot of financial and material resources in the research and development of new drugs every year to ensure our leading position in the pharmaceutical industry. For your company, our company has always been very concerned, especially the strong R&D capabilities expressed by the R&D institutions under Mr. Liu, which we admire very much. "Aemond knows that today is destined to be a difficult negotiation, but he can't help but talk about it, you should be afraid of competition when doing business, but when your opponent competes with you in a way that you can never imagine, it brings you almost despair.

Aemond knew that no matter what, he would never be able to put the new drugs developed by Boyuan Group on the market, or change the direction of Boyuan Group's current research. The listing of a statin is enough to prove the strength of Boyuan, if there are other drugs in Boyuan Group now, then it is conceivable what awaits them, to put it bluntly, as long as Boyuan Group's drugs are listed, all the drugs of other manufacturers will be taken off the shelves. Even if they are not removed from the shelves, compared with Boyuan Group's drugs, they do not have absolute core competitiveness, this is the market, this is the competitiveness.

Liu Tao looked at Aemond with a smile, of course he knew what Aemond was thinking, and he also knew the reason why Pfizer came to negotiate with him. Although Boyuan Group and its subordinate pharmaceutical companies have not yet come up with a drug that shocks the world, no one dares to ignore the scientific research strength of Boyuan Group. In particular, Aemond himself is the Taishan Beidou of the pharmaceutical industry, and he does not believe that Boyuan Group will come up with such a heavy cost to develop new drugs.

Liu Tao smiled and looked at Aemond, but he never said a word. Saying anything is superfluous and meaningless. The most important thing for capitalists is their interests, and Pfizer's coming to him this time can only show that he has a vision and met the impact that Boyuan Group is about to launch on the entire pharmaceutical industry as soon as possible.

"Mr. Liu, so we hope that the two sides can cooperate sincerely, instead of falling into competition like this." Aemond finally stated his purpose, although he was very reluctant to believe that Boyuan Group could develop a drug comparable to Pfizer Group, but they still did not dare to be careless.

"Cooperation? Of course, Boyuan Group has always liked to cooperate with major companies, and of course, as a top international company, Pfizer is naturally one of the partners we are seeking. Liu Tao's words made Aemond breathe a sigh of relief, how big is the benefit cake of drugs. Insiders really know too well that if Boyuan Group enters strongly, it is very likely that they will lose more than half of their interests in this area.

"Cooperation, that's the best, there are always a lot of risks in the development of new drugs. We Pfizer Group has the best R&D team in the world, as long as Mr. Liu is willing to cooperate, we can jointly fund the research and development of new drugs, I believe that as long as we join forces, new drugs will appear on the market in a short time. Aemond had a smug smile on his face and said that if the R&D team Pfizer said that he was the second, then absolutely no one dared to say that he was the first.

"I've always known the strength of the Pfizer group. Especially since I was an intern at Pfizer for half a year. Liu Tao's smile made Aemond very proud: "But." Mr. Aemond, one of the things that you have emphasized to me from the beginning to the present is the huge cost of drug development, but I want to tell you about it. Boyuan Group is very rich. ”

"Our R&D team may not be as good as your Pfizer. Probably not the best R&D team in the world. However, we Boyuan Group absolutely have the confidence and strength to build the best R&D team in the world. Liu Tao's words made Aemond's face change slightly, and he probably understood what Aemond's words meant: "Mr. Aemond, I have seriously considered the matter of cooperating with Pfizer. But after thinking about it, I decided to give up. ”

"Why? Is it because of the lack of sincerity or interest of our group? ”

"The conditions given by your company are good enough, but unfortunately there is still a big gap between what I thought." Liu Tao said to Aemond with a smile: "You know that our Boyuan Group has a rule for doing business, that is, some industries can make money, and some industries can not make money. I'll give you the most direct example, which is that I have two real estate sites in my hometown and two real estate sites in Pearl City. Among them, the land in my hometown is sold at almost zero profit, and the real estate in Pearl City, I have to earn at least 20% of this point, and it may even be higher, and his house price is definitely the most expensive real estate in Pearl City, there is no one. ”

Aemond looked at Liu Tao thoughtfully, he didn't believe that Liu Tao was not moved by the medicine, and it was all fake to say that he was not moved. Although drugs have always been labeled as one of the welfare products that human beings should get for free, in fact, the most profitable corporate pharmaceutical companies every year are also among them. Of course, this is not to say that the price of drugs is inflated by everyone, but because the cost of drug research and development is indeed very high, but this qiē is nothing in Liu Tao's opinion.

"I probably understand what Mr. Liu means, but Mr. Liu, you should know the reason why the drug is expensive."

"Of course I know, I know everything better than anyone else." Liu Tao said to Aemond with a smile: "However, since we Boyuan Group have made up our minds, we will naturally do it to the end. In my opinion, medicine has always been one of the welfare products for the benefit of mankind, and it should not be elevated to the point that patients cannot afford to take medicine. ”

"The price of our company's drugs will not be more than one dollar, so fundamentally speaking, there is no common language between us to talk about interests." Liu Tao smiled and said to Aemond, although Liu Tao has been salivating over the drug cake for a long time and has already begun to do it.

Drugs are the next fist product of Boyuan Group, but the price is definitely not a fist product. Liu Tao is not a great good person, but he is absolutely unwilling to be that evil person. The price of drugs can not be lowered just by relying on Boyuan, but Boyuan Group will never use the price of domestic drugs and imported drugs, in Liu Tao's words, Boyuan Group's drugs are the best efficacy, and the price of domestic drugs is taken.

"But Mr. Liu, our company's two drugs for the treatment of hypertension have been fully affirmed by the world, so why should Mr. Liu develop new drugs by himself? You know that the cost and risk of R&D of new drugs are very high, and according to our experts, it is difficult for you to develop better drugs than us, Mr. Liu, why do you do this? ”

"I have my reasons, the reason why I want to see you is not to hear what you have to say, but to make a deal with you."

Aemond stretched out his hand to Liu Tao and motioned for Liu Tao to continue, like Pfizer Group, the Boyuan Group can also be said to be making money every day, and even getting more profits than them. The general business is discussed by the heads of various sub-departments of Boyuan, and only when there is a big business, their president Liu Tao will really come out.

"Two businesses, one is that I invested in the acquisition of 25% of your Pfizer Group's equity, and the other is that I need your two drugs, here are all the conditions listed by our Boyuan Group, you can take a look." Mi Yulian placed a copy of the text in front of Aemond.

"Impossible, this is absolutely impossible." Aemond closed the text in his hand, what are you kidding, when Boyuan Group wanted to acquire 20% of their equity, Aemond had already thought of a reason to resign, but he didn't expect Boyuan Group to give him such a good reason.

"Okay, you'll talk about it after watching it."

"Mr. Liu, we are here with sincerity, otherwise our company would not have sent me here to negotiate with you." Aemond said to Liu Tao with a solemn face, not that Liu Tao put forward any unreasonable conditions, but that Liu Tao was so confident that he wanted to exchange 25% of the equity of Pfizer Group with only the joint sales rights of the two drugs.

No one knows how much the market value of Pfizer Group is, but it will definitely not be less than 500 billion US dollars, and Boyuan Group just wants to get 20% of Pfizer's equity with two drugs. You must know that obtaining this 20% equity is equivalent to controlling the Pfizer group.

"Mr. Liu, do you really want to compete with our group to the end?"

"Yes or no, it depends on what the people in your group think." Liu Tao smiled and said to everyone: "I want to buy Pfizer Group just to buy your brand, you have cooperated with many internationally renowned magazines and publications over the years, I need this channel, and I want the world's largest pharmaceutical company." ”

"Mr. Liu, the acquisition is impossible, we can only cooperate with each other."

"I have no objection to cooperation, but you should also know that our Boyuan Group is now pursuing more than just profits, if your company is willing to cooperate with us, we must reduce the price of drugs."

"I don't have the right to decide." Aemond looked at Liu Tao with a resolute face, the price of drugs is the foundation of the survival of drug companies, and there are many factors that determine the finished product, the most important of which is the cost and risk of research and development. The high price of drugs is not only because of good efficacy and imports, but also because of the research costs behind them. (To be continued......)